Singapore: US-based Molecular Targeting Technologies (MTTI) and National Health Research Institutes (NHRI) of Taiwan hav...
Singapore: Australian biotechnology company Virax plans to acquire oncology company AKTivate Therapeutics and its novel ...
Singapore: Agency for Science, Technology and Research (A*STAR) and Duke-National University of Singapore Graduate Medic...
Scientists at the Okayama University in Japan have announced that their studies have revealed how a diabetes drug helps ...
Singapore: GlaxoSmithKline and Theravance have withdrawn license application for the use of inhaled drug fluticasone fur...
Singapore: Global pharma company Novartis has confirmed positive results from two pivotal phase III studies evaluating i...
Singapore: Researchers from the Nanyang Technological University, Singapore have developed a new antibody that has shown...
Singapore: Taiwan based TaiGen Biotechnology has collaborated with R-Pharm, a Russian pharmaceutical company, to develop...
Singapore: Verastem, a biopharmaceutical company focused on discovering and developing drugs to treat breast and other c...
Singapore: Australia and Indonesia are jointly working towards the research to understand prevalence of AIDS and cancer ...
Singapore: Australian biotech firm, Bionomics, has partnered with Merck for research and license agreement for its BNC37...
Singapore: Australia's Medical Research Commercialisation Fund (MRCF) has funded the start-up firm Solvanix, an early st...
Singapore: Pharmaceutical firms, Roche, Meiji Seika Pharma and Fedora have entered into a license agreement for the deve...
Singapore: Taiwan based Delta Electronics has invested in Singapore to develop next-generation infectious disease detec...
Professor (Dr) David Price has been fighting the scourge of respiratory diseases throughout his life and is considered o...
Singapore: Eli Lilly officially opened the Lilly China Research and Development Center (LCRDC) on May 30, keeping with i...
Singapore: Australia-based biopharmaceutical company, Specialised Therapeutics Australia (STA), has achieved positive re...
Singapore: Brisbane-based R&D company Alchemia has recruited the 390th patient for the pivotal phase III clinical tr...
